founding-member-of-QUTAC founding-member-of-QUTAC Together, the members of this newly founded consortium want to explore industrial applications for quantum computing
Financial health Financial health We constantly review our salaries to make sure they stay competitive in each market but we also provide wider support for financial health.
Learning and development Learning and development We help people grow professionally by maximizing our talent and giving them room to evolve within the company.
Innovation in medicinal chemistry Innovation in medicinal chemistry Darryl McConnell, Research Site Head, Austria and Jürgen Mack, Medicinal Chemistry, explain how we are working to unlock unsolved diseases
Partnership with IBM to accelerate new antibody therapies Partnership with IBM to accelerate new antibody therapies Boehringer Ingelheim collaborates with IBM to advance generative AI and foundation models for therapeutic antibody development
Closing healthcare gaps with continued vaccination campaigns Closing healthcare gaps with continued vaccination campaigns How we continue combating rabies through collaborative efforts and the use of drone delivery in rural Kenya.
Boehringer unveils first global sustainability publication Boehringer unveils first global sustainability publication Boehringer Ingelheim unveils its first global sustainability publication ‘Imagine’
Animal Welfare through environmental sustainability Animal Welfare through environmental sustainability Producing honey and contributing to environmental sustainability during your work hours.
Ileitis prevention vaccination Lawsonia intracellularis pig Ileitis prevention vaccination Lawsonia intracellularis pig Cause, impact and prevention: Learn the essentials about Ileitis
New Therapeutic Antibody Discovery Collaboration New Therapeutic Antibody Discovery Collaboration Proprietary antibody libraries to help discover therapeutic antibodies against multiple targets
Boehringer acquires T3 Pharma Boehringer acquires T3 Pharma Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma
Plasmid DNA Production | BioXcellence Plasmid DNA Production | BioXcellence Discover our range of plasmid DNA production solutions from research to GMP.
Over 100 billion birds vaccinated with VAXXITEK Over 100 billion birds vaccinated with VAXXITEK Boehringer Ingelheim celebrates that over 100 billion birds have been vaccinated with VAXXITEK® HVT + IBD in October 2018.
Who are we? Who are we? Started in 1885 by Albert Boehringer, this independent family-owned company has grown into a top contributor in Human Pharma and Animal Health.
Our people Our people Ambition. Passion. Integrity. Commitment. Empathy. Individuality. We expect these qualities at all levels.
Feline diabetes: how to detect and treat it Feline diabetes: how to detect and treat it What are the symptoms of diabetes in cats, and how do you manage this chronic disease? Find the answers here.
Work life balance Work life balance It's important that employees have a balance between professional and personal lives, so we offer various leave options and flexible working schedules.
"Medical innovations and healthcare for everyone" "Medical innovations and healthcare for everyone" African Americans are often excluded from healthcare options and medical innovations. We want to learn how we can better serve them.
Boehringer Ingelheim good 2021 business performance Boehringer Ingelheim good 2021 business performance 2021 was a good year for patients, for animal owners and for Boehringer Ingelheim.
World Water Day: Good Health Hinges on Good Water World Water Day: Good Health Hinges on Good Water Clean, safe and accessible water is the most basic prerequisite for life and health
Human-dog relationship – a historical perspective Human-dog relationship – a historical perspective The human-dog relationship – a historical perspective
Protein Degraders in Cancer Protein Degraders in Cancer Boehringer Ingelheim scientists and their partners are exploring how protein degraders could bring so-called undruggable cancer targets within reach
Blue internal teat sealant now in dairy mastitis portfolio Blue internal teat sealant now in dairy mastitis portfolio Boehringer Ingelheim adds blue internal teat sealant to its dairy mastitis portfolio
New biomass power plant Ingelheim New biomass power plant Ingelheim Boehringer Ingelheim produces its own green energy